Prevalence and the associated burden of illness of symptoms of diabetic peripheral neuropathy and diabetic retinopathy

Journal of Diabetes and its Complications

Volumn 21, Issue 5, 2007, Pages 306-314

  Candrilli, Sean D ^a   Davis, Keith L ^a   Kan, Hong J ^b   Lucero, Melanie A ^a   Rousculp, Matthew D ^b  

^a RTI HEALTH SOLUTIONS   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Burden of illness; Diabetes; Diabetic peripheral neuropathy; Diabetic retinopathy

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; FEMALE; GLYCEMIC CONTROL; HEALTH CARE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SMOKING HABIT;

ADULT; AGED; AGED, 80 AND OVER; CONTINENTAL POPULATION GROUPS; COST OF ILLNESS; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; EDUCATIONAL STATUS; ETHNIC GROUPS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; OBESITY; PREVALENCE; SMOKING; UNITED STATES;

EID: 34548393288     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2006.08.002     Document Type: Article

References (15)

1. American Diabetes Association. National diabetes fact sheet. Available at: (2002). http://www.diabetes.org/diabetes-statistics/national-diabetes-fact-sheet .jsp [accessed on January 31, 2006]
2. Benson W.H., and Farber M.E. Diabetic retinopathy in a rural diabetic population-Prevalence and risk. West Virginia Medical Journal 85 4 (1989) 141-143
3. Caro J.J., Ward A., and O'Brien J. Lifetime costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care 25 (2002) 476-481
4. Centers for Disease Control and Prevention. National Center for Health Statistics: NHANES 1999-2000 addendum to the NHANES III analytic guidelines [on-line]. Available from the Centers for Disease Control at (2002). http://www.cdc.gov/nchs/data/nhanes/guidelines1.pdf
5. Dyck P.J., Kratz K.M., Karnes J.L., Litchy W.J., Klein R., Pach J.M., et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: The Rochester Diabetic Neuropathy Study. Neurology 43 4 (1993) 2345
6. Dyck P.J.B., and Dyck P.J. Diabetic polyneuropathy. In: Dyck P.J., and Thomas P.K. (Eds). Diabetic neuropathy. 2nd ed. (1999), W.B. Saunders Co., Philadelphia, PA 255-278
7. Franklin G.M., Kahn L.B., Baxter J., Marshall J.A., and Hamman R.F. Sensory neuropathy in non-insulin dependent diabetes mellitus: The San Luis Valley Diabetes Study. American Journal of Epidemiology 134 4 (1990) 633-643
8. Gordois A., Scuffham P., Shearer A., Oglesby A., and Tobian J.A. The health care costs of diabetic peripheral neuropathy in the U.S. Diabetes Care 26 6 (2003) 1790-1795
9. Gregg E.W., Sorlie P., Paulose-Ram R., Gu Q., Eberhardt M.S., Wolz M., et al. Prevalence of lower-extremity disease in the U.S. adult population ≥40 years of age with and without diabetes. Diabetes Care 27 7 (2004) 1591-1597
10. Hamman R.F., Mayer E.J., Moo-Young G.A., Hildebrandt W., Marshall J.A., and Baxter J. Prevalence of risk factors of diabetic retinopathy in non-Hispanic whites and Hispanics with NIDDM: San Luis Valley Diabetes Study. Diabetes 38 10 (1989) 1231-1237
11. Harris M., Eastman R., and Cowie C. Symptoms of neuropathy in adults with NIDDM in the U.S. population. Diabetes Care 16 (1993) 1446-1452
12. Harris M.I., Klein R., Cowie C.C., Rowland M., and Byrd-Holt D.D. Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes?. Diabetes Care 21 8 (1998) 1230-1235
13. Kempen J.H., O'Colmain B.J., Leske M.C., Haffner S.M., Klein R., Moss S.E., et al. The prevalence of diabetic retinopathy among adults in the United States. Archives of Ophthalmology 22 4 (2004) 552-563
14. Klein R., Klein B.E., Moss S.E., Davis M.D., and DeMets D.L. The Wisconsin epidemiologic study of diabetic retinopathy: Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Archives of Ophthalmology 102 4 (1984) 527-532
15. Remak E., Chambers M., Kennedy-Martin Y., and Oglesby A. The economic burden of diabetic retinopathy-The distribution of costs. Diabetes 52 (2003) A268-A269